Clinical Trial Update: Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial studying the pharmacokinetics and safety of obeticholic acid in participants with primary biliary cholangitis and hepatic impairment ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Liver Cirrhosis

Drugs mentioned

• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Liver Cirrhosis, Biliary | Phase 4 | Status: TERMINATED | Results posted: 2022-09-06